MedPath

Acarbose

Acarbose Tablets

Approved
Approval ID

bf8500e1-9037-43f5-855b-d336d92d5cb7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 29, 2021

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

acarbose

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-5829
Application NumberANDA090912
Product Classification
M
Marketing Category
C73584
G
Generic Name
acarbose
Product Specifications
Route of AdministrationORAL
Effective DateDecember 26, 2019
FDA Product Classification

INGREDIENTS (5)

ACARBOSEActive
Quantity: 100 mg in 1 1
Code: T58MSI464G
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acarbose - FDA Drug Approval Details